Use of ivermectin in the treatment of Covid-19: A pilot trial

OBJECTIVES: In this randomized open-label trial pilot study we assessed the antiviral effects and safety of various doses of ivermectin in patients with mild clinical symptoms of COVID-19. METHODS: Patients were randomly assigned to receive standard of care (SOC) treatment at hospital admission; SOC...

Descripción completa

Detalles Bibliográficos
Autores principales: Pott-Junior, Henrique, Paoliello, Mônica Maria Bastos, Miguel, Alice de Queiroz Constantino, da Cunha, Anderson Ferreira, de Melo Freire, Caio Cesar, Neves, Fábio Fernandes, da Silva de Avó, Lucimar Retto, Roscani, Meliza Goi, dos Santos, Sigrid De Sousa, Chachá, Silvana Gama Florêncio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
COVID-19 Pandemic: Health impact and Novel research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942165/
https://www.ncbi.nlm.nih.gov/pubmed/33723507
http://dx.doi.org/10.1016/j.toxrep.2021.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942165/
https://www.ncbi.nlm.nih.gov/pubmed/33723507
http://dx.doi.org/10.1016/j.toxrep.2021.03.003

Ejemplares similares